Literature DB >> 8112845

Granulocyte-macrophage colony-stimulating factor is not involved in production of reactive nitrogen intermediates by or toxoplasmastatic activity of gamma interferon-activated murine macrophages.

A Buisman1, J T van Dissel, J A Langermans, R van Furth.   

Abstract

The induction of reactive nitrogen intermediates (RNI) and toxoplasmastatic activity of murine macrophages by recombinant gamma interferon (rIFN-gamma) is mediated by an autocrine pathway involving tumor necrosis factor alpha (TNF-alpha). To investigate whether cytokines other than TNF-alpha play a role in the activation of these effector functions, granulocyte-macrophage colony-stimulating factor (GM-CSF) was studied. Recombinant GM-CSF (rGM-CSF) could stimulate peritoneal macrophages, since this cytokine stimulated the production of prostaglandin E2 by these cells. However, rGM-CSF did not induce either the release of RNI by or the toxoplasmastatic activity of macrophages. rGM-CSF in combination with various concentrations of rIFN-gamma did not enhance these effector functions more than rIFN-gamma alone. Furthermore, neutralization of endogenously produced GM-CSF by monoclonal antibodies did not affect the release of RNI by or the toxoplasmastatic activity of rIFN-gamma-activated macrophages. Together these results indicate that GM-CSF is not involved in RNI production by and toxoplasmastatic activity of IFN-gamma-activated murine macrophages.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8112845      PMCID: PMC186232          DOI: 10.1128/iai.62.3.1121-1124.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  A serum facted by newborn calf serum.

Authors:  D van Waarde; E Hulsing-Hesselink; R van Furth
Journal:  Cell Tissue Kinet       Date:  1976-01

2.  The purification and characterization of rat gamma interferon by use of two monoclonal antibodies.

Authors:  P H van der Meide; M Dubbeld; K Vijverberg; T Kos; H Schellekens
Journal:  J Gen Virol       Date:  1986-06       Impact factor: 3.891

3.  T cell-monocyte interactions in the production of humoral factors regulating human granulopoiesis in vitro.

Authors:  F Herrmann; S A Cannistra; J D Griffin
Journal:  J Immunol       Date:  1986-04-15       Impact factor: 5.422

4.  Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma.

Authors:  D J Stuehr; M A Marletta
Journal:  J Immunol       Date:  1987-07-15       Impact factor: 5.422

5.  Granulocyte-macrophage colony-stimulating factor enhances selective effector functions of tissue-derived macrophages.

Authors:  D L Coleman; J A Chodakewitz; A H Bartiss; J W Mellors
Journal:  Blood       Date:  1988-08       Impact factor: 22.113

6.  Synergistic activation of human monocytes by granulocyte-macrophage colony-stimulating factor and IFN-gamma. Increased TNF-alpha but not IL-1 activity.

Authors:  P H Hart; G A Whitty; D S Piccoli; J A Hamilton
Journal:  J Immunol       Date:  1988-09-01       Impact factor: 5.422

7.  Endogenous tumor necrosis factor alpha is required for enhanced antimicrobial activity against Toxoplasma gondii and Listeria monocytogenes in recombinant gamma interferon-treated mice.

Authors:  J A Langermans; M E van der Hulst; P H Nibbering; R van Furth
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

8.  Interferon-gamma: the major mediator of resistance against Toxoplasma gondii.

Authors:  Y Suzuki; M A Orellana; R D Schreiber; J S Remington
Journal:  Science       Date:  1988-04-22       Impact factor: 47.728

9.  Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon gamma.

Authors:  S G Reed; C F Nathan; D L Pihl; P Rodricks; K Shanebeck; P J Conlon; K H Grabstein
Journal:  J Exp Med       Date:  1987-12-01       Impact factor: 14.307

10.  Cloning and expression of the chromosomal immune interferon gene of the rat.

Authors:  R Dijkema; P H van der Meide; P H Pouwels; M Caspers; M Dubbeld; H Schellekens
Journal:  EMBO J       Date:  1985-03       Impact factor: 11.598

View more
  2 in total

1.  Granulocyte-macrophage colony-stimulating factor (GM-CSF) reduces toxoplasmastatic activity of human monocytes via induction of prostaglandin E2 (PGE2).

Authors:  F G Delemarre; A Stevenhagen; R Van Furth
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

2.  Cytokine-mediated activation of macrophages from Mycobacterium bovis BCG-resistant and -susceptible mice: differential effects of corticosterone on antimycobacterial activity and expression of the Bcg gene (Candidate Nramp).

Authors:  D H Brown; W LaFuse; B S Zwilling
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.